About

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Lupus Forum content is free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.

Membership of the Lupus Forum is free to everyone. Register as a member and have unlimited free access to all of the materials contained within the site.

Register now!
Register today!
2024 Lupus Forum Members Survey Results

NEW Monthly literature search podcasts – available now

Our Steering Committee Member Professor Chi-Chiu Mok is joined by Professor Chiu Wai Shirley Chan in the latest Lupus Forum podcast. Together they discuss the use of machine learning to identify clusters of SLE patients based on peripheral B cell and plasma cell subsets. They will also discuss the potential predictors of efficacy and safety of belimumab and telitacicept in SLE, and the altering effect of belimumab on autoimmunity in SLE.

Latest Updates

Publications ▼
All
Publication thumbnail: Unsupervised machine learning identifies distinct systemic lupus erythematosus patient endotypes with differential response to belimumab

Unsupervised machine learning identifies distinct systemic lupus erythematosus patient endotypes with differential response to belimumab

Publication thumbnail: LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Publication thumbnail: Belimumab efficacy in mucocutaneous lupus erythematosus: a large post-hoc analysis from five phase III clinical trials

Belimumab efficacy in mucocutaneous lupus erythematosus: a large post-hoc analysis from five phase III clinical trials

Publication thumbnail: Evolution and trajectory of B-cell targeted therapies in rheumatic diseases

Evolution and trajectory of B-cell targeted therapies in rheumatic diseases

Steering Committee